BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gulyás K, Horváth Á, Végh E, Pusztai A, Szentpétery Á, Pethö Z, Váncsa A, Bodnár N, Csomor P, Hamar A, Bodoki L, Bhattoa HP, Juhász B, Nagy Z, Hodosi K, Karosi T, Fitzgerald O, Szücs G, Szekanecz Z, Szamosi S, Szántó S. Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol 2020;39:167-75. [DOI: 10.1007/s10067-019-04771-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Krüger GS, Silva CJ, Teodoro RB, Michelin MA. Osteoimmunology in rheumatoid arthritis: a comparison between conventional therapies and biologics.. [DOI: 10.21203/rs.3.rs-2443943/v1] [Reference Citation Analysis]
2 Azadeh H. Association between disease‐modifying antirheumatic drugs and bone turnover biomarkers. Int J of Rheum Dis 2022. [DOI: 10.1111/1756-185x.14550] [Reference Citation Analysis]
3 Tao S, Cao F, Sam NB, Li H, Feng Y, Ni J, Wang P, Li X, Pan H. Dickkopf-1 as a promising therapeutic target for autoimmune diseases. Clinical Immunology 2022;245:109156. [DOI: 10.1016/j.clim.2022.109156] [Reference Citation Analysis]
4 Navarro I, González-lópez MA, Sierra I, Olmos JM, Blanco R, Hernández JL. Bone Metabolism in Patients with Hidradenitis Suppurativa: A Case-control Study. Acta Derm Venereol 2022;102:adv00825. [DOI: 10.2340/actadv.v102.3504] [Reference Citation Analysis]
5 Khoshroo A, Ramezani K, Moghimi N, Bonakdar M, Ramezani N. The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients. Inflammopharmacol 2022. [DOI: 10.1007/s10787-022-01088-7] [Reference Citation Analysis]
6 Hussein R, Aboukhamis I. The association of serum RANKL levels with disease activity and hematological parameters in Syrian patients with rheumatoid arthritis. Biochem Biophys Rep 2022;32:101373. [PMID: 36304516 DOI: 10.1016/j.bbrep.2022.101373] [Reference Citation Analysis]
7 Zhao H, Li L, Zhao N, Lu A, Lu C, He X. The effect of long non-coding RNAs in joint destruction of rheumatoid arthritis. Front Cell Dev Biol 2022;10:1011371. [DOI: 10.3389/fcell.2022.1011371] [Reference Citation Analysis]
8 Sakthiswary R, Uma Veshaaliini R, Chin K, Das S, Sirasanagandla SR. Pathomechanisms of bone loss in rheumatoid arthritis. Front Med 2022;9. [DOI: 10.3389/fmed.2022.962969] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Hussein R, Kakaje A, Aboukhais I. The role of sclerostin in rheumatoid arthritis in a Syrian population: a potential indicator of disease activity in newly-diagnosed patients.. [DOI: 10.21203/rs.3.rs-1940285/v1] [Reference Citation Analysis]
10 Sobral D, Fernandes AF, Sardoo A, Bernardes M, Pinto P, Santos H, Lagoas-gomes J, Tavares-costa J, Ap Silva J, Dias JM, Bernardo A, Gaillard J, Armengaud J, Benes V, Domingues L, Gouveia N, Maia S, Branco JC, Coelho AV, Pimentel-santos FM. MULTI-OMICS TEMPORAL PROFILING OF AXIAL SPONDYLOARTHRITIS PATIENTS REVEALS AN ASSOCIATION OF THERAPEUTIC RESPONSE TO ADALIMUMAB WITH DISEASE ACTIVITY AND INNATE / ADAPTIVE IMMUNITY.. [DOI: 10.1101/2022.08.02.22278314] [Reference Citation Analysis]
11 Wiebe E, Huscher D, Schaumburg D, Palmowski A, Hermann S, Buttgereit T, Biesen R, Burmester GR, Palmowski Y, Boers M, Stone JH, Dejaco C, Buttgereit F. Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease. Ann Rheum Dis 2022:annrheumdis-2022-222339. [PMID: 35680387 DOI: 10.1136/annrheumdis-2022-222339] [Reference Citation Analysis]
12 Laurindo LF, de Maio MC, Barbalho SM, Guiguer EL, Araújo AC, de Alvares Goulart R, Flato UAP, Júnior EB, Detregiachi CRP, dos Santos Haber JF, Bueno PCS, Girio RSJ, Eleutério RG, Bechara MD. Organokines in Rheumatoid Arthritis: A Critical Review. IJMS 2022;23:6193. [DOI: 10.3390/ijms23116193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Evangelatos G, Bamias G, Kitas GD, Kollias G, Sfikakis PP. The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era. Rheumatol Int 2022. [PMID: 35503130 DOI: 10.1007/s00296-022-05136-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kirazlı Y, Çınar E. Osteoporosis: An Underdiagnosed Problem in Patients with Ankylosing Spondylitis. Tod 2022;28:1-5. [DOI: 10.4274/tod.galenos.2022.68094] [Reference Citation Analysis]
15 Soós B, Szentpétery Á, Raterman HG, Lems WF, Bhattoa HP, Szekanecz Z. Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases. Nat Rev Rheumatol 2022. [PMID: 35273387 DOI: 10.1038/s41584-022-00764-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
16 Maeda K, Yoshida K, Nishizawa T, Otani K, Yamashita Y, Okabe H, Hadano Y, Kayama T, Kurosaka D, Saito M. Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments. IJMS 2022;23:2871. [DOI: 10.3390/ijms23052871] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
17 Soós B, Fagyas M, Horváth Á, Végh E, Pusztai A, Czókolyová M, Csongrádi A, Hamar A, Pethő Z, Bodnár N, Kerekes G, Hodosi K, Szekanecz É, Szamosi S, Szántó S, Szűcs G, Papp Z, Szekanecz Z. Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients. Front Med (Lausanne) 2021;8:785744. [PMID: 35155468 DOI: 10.3389/fmed.2021.785744] [Reference Citation Analysis]
18 Lems W, Miceli-richard C, Haschka J, Giusti A, Chistensen GL, Kocijan R, Rosine N, Jørgensen NR, Bianchi G, Roux C. Bone Involvement in Patients with Spondyloarthropathies. Calcif Tissue Int. [DOI: 10.1007/s00223-021-00933-1] [Reference Citation Analysis]
19 Atas N, Çakır B, Bakır F, Uçar M, Satış H, Güz GT, Demirel KD, Babaoğlu H, Salman RB, Güler AA, Karadeniz H, Haznedaroğlu Ş, Göker B, Öztürk MA, Tufan A. The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis. Clin Rheumatol. [DOI: 10.1007/s10067-022-06070-w] [Reference Citation Analysis]
20 Lechtenboehmer CA, Burkard T, Reichenbach S, Walker UA, Burden AM, Hügle T. Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis. Arthritis Res Ther 2021;23:267. [PMID: 34702319 DOI: 10.1186/s13075-021-02654-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Pusztai A, Hamar A, Czókolyová M, Gulyás K, Horváth Á, Végh E, Pethő Z, Szamosi S, Balogh E, Bodnár N, Bodoki L, Szentpétery Á, Bhattoa HP, Kerekes G, Juhász B, Szekanecz É, Hodosi K, Domján A, Szántó S, Raterman HG, Lems WF, Szekanecz Z, Szűcs G. Associations of vascular and bone status in arthritis patients. Sci Rep 2021;11:19504. [PMID: 34593938 DOI: 10.1038/s41598-021-99071-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Juhász B, Gulyás K, Horváth Á, Végh E, Pusztai A, Szentpétery Á, Pethő Z, Bodnár N, Hamar A, Bodoki L, Bhattoa HP, Szekanecz É, Hodosi K, Domján A, Szamosi S, Horváth C, Szántó S, Szűcs G, Raterman HG, Lems WF, FitzGerald O, Szekanecz Z. Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients. BMC Musculoskelet Disord 2021;22:817. [PMID: 34556105 DOI: 10.1186/s12891-021-04708-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Nagase Y, Nagashima M, Shimane K, Nishikawa T, Naito M, Tanaka S. Effect of TNF inhibitors with bisphosphonates vs bisphosphonates alone on bone mineral density and bone and cartilage biomarkers at 1 year in patients with rheumatoid arthritis: A prospective study. Mod Rheumatol 2021:roab037. [PMID: 34910195 DOI: 10.1093/mr/roab037] [Reference Citation Analysis]
24 Olic Akrapovic I, Radic M, Tonkic A. Is there higher percentage of undetected osteopenia and osteoporosis among patients with ulcerative colitis in Saudi Arabia? World J Gastroenterol 2021; 27(27): 4481-4483 [PMID: 34366618 DOI: 10.3748/wjg.v27.i27.4481] [Reference Citation Analysis]
25 Jura-Półtorak A, Szeremeta A, Olczyk K, Zoń-Giebel A, Komosińska-Vassev K. Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors. J Clin Med 2021;10:2905. [PMID: 34209821 DOI: 10.3390/jcm10132905] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
26 Poutoglidou F, Pourzitaki C, Manthou ME, Samoladas E, Saitis A, Malliou F, Kouvelas D. Infliximab prevents systemic bone loss and suppresses tendon inflammation in a collagen-induced arthritis rat model. Inflammopharmacology 2021;29:661-72. [PMID: 33982199 DOI: 10.1007/s10787-021-00815-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
27 Wang L, Che K, Liu Y. Pharmacokinetics, distribution and efficacy of triptolide PLGA microspheres after intra-articular injection in a rat rheumatoid arthritis model. Xenobiotica 2021;51:703-15. [PMID: 33938387 DOI: 10.1080/00498254.2021.1923860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Poutoglidou F, Pourzitaki C, Manthou ME, Samoladas E, Malliou F, Saitis A, Kouvelas D. Effects of Long-Term Methotrexate, Infliximab, and Tocilizumab Administration on Bone Microarchitecture and Tendon Morphology in Healthy Wistar Rats. Cureus 2021;13:e14696. [PMID: 34055540 DOI: 10.7759/cureus.14696] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Hamar A, Szekanecz Z, Pusztai A, Czókolyová M, Végh E, Pethő Z, Bodnár N, Gulyás K, Horváth Á, Soós B, Bodoki L, Bhattoa HP, Nagy G, Tajti G, Panyi G, Szekanecz É, Domján A, Hodosi K, Szántó S, Szűcs G, Szamosi S. Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis. Osteoporos Int 2021;32:1621-9. [PMID: 33559714 DOI: 10.1007/s00198-021-05871-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
30 Kaaij MH, Helder B, van Mens LJJ, van de Sande MGH, Baeten DLP, Tas SW. Anti-IL-17A treatment reduces serum inflammatory, angiogenic and tissue remodeling biomarkers accompanied by less synovial high endothelial venules in peripheral spondyloarthritis. Sci Rep 2020;10:21094. [PMID: 33273664 DOI: 10.1038/s41598-020-78204-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
31 Liu J, Liu J, Liu L, Zhang G, Zhou A, Peng X. The gut microbiota alteration and the key bacteria in Astragalus polysaccharides (APS)-improved osteoporosis. Food Research International 2020;138:109811. [DOI: 10.1016/j.foodres.2020.109811] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
32 Rotta D, Fassio A, Rossini M, Giollo A, Viapiana O, Orsolini G, Bertoldo E, Gatti D, Adami G. Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment. Front Med (Lausanne) 2020;7:613720. [PMID: 33335907 DOI: 10.3389/fmed.2020.613720] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
33 Chin KY, Wong SK, Ekeuku SO, Pang KL. Relationship Between Metabolic Syndrome and Bone Health - An Evaluation of Epidemiological Studies and Mechanisms Involved. Diabetes Metab Syndr Obes 2020;13:3667-90. [PMID: 33116718 DOI: 10.2147/DMSO.S275560] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
34 Sachinvala ND, Teramoto N, Stergiou A. Proposed Neuroimmune Roles of Dimethyl Fumarate, Bupropion, S-Adenosylmethionine, and Vitamin D3 in Affording a Chronically Ill Patient Sustained Relief from Inflammation and Major Depression. Brain Sci 2020;10:E600. [PMID: 32878267 DOI: 10.3390/brainsci10090600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]